Literature DB >> 19254115

Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts.

Ting-Hsien Chuang1, Christopher Stabler, Agneta Simionescu, Dan T Simionescu.   

Abstract

Tissue-engineered vascular grafts require elastic, acellular porous scaffolds with controlled biodegradability and properties matching those of natural arteries. Elastin would be a desirable component for such applications, but elastin does not easily regenerate experimentally. Our approach is to develop tubular elastin scaffolds using decellularization and removal of collagen from porcine carotid arteries ( approximately 5 mm diameter) using alkaline extraction. Because elastin is susceptible to rapid degeneration after implantation, scaffolds were further treated with penta-galloyl glucose (PGG), an established polyphenolic elastin-stabilizing agent. Scaffolds were compared in vitro with detergent-decellularized arteries for structure, composition, resistance to degradation, mechanical properties, and cytotoxicity and in vivo for cell infiltration and remodeling potential. Results showed effective decellularization and almost complete collagen removal by alkaline extraction. PGG-treated elastin scaffolds proved to be resistant to elastase digestion in vitro, maintained their cylindrical shapes, showed high resistance to burst pressures, and supported growth of endothelial cells and fibroblasts. In vivo results showed that PGG treatment reduced the rate of elastin biodegradation and controlled cell infiltration but did not hamper new collagen and proteoglycan deposition and secretion of matrix-degrading proteases. Alkali-purified, PGG-treated tubular arterial elastin scaffolds exhibit many desirable properties to be recommended for clinical applications as vascular grafts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254115      PMCID: PMC2792047          DOI: 10.1089/ten.TEA.2008.0394

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   4.080


  55 in total

1.  Biomaterials for tissue engineering.

Authors:  B S Kim; C E Baez; A Atala
Journal:  World J Urol       Date:  2000-02       Impact factor: 4.226

2.  Novel porous aortic elastin and collagen scaffolds for tissue engineering.

Authors:  Qijin Lu; Kavitha Ganesan; Dan T Simionescu; Narendra R Vyavahare
Journal:  Biomaterials       Date:  2004-10       Impact factor: 12.479

Review 3.  Molecular aspects of vascular tissue engineering.

Authors:  David A Vorp; Timothy Maul; Alejandro Nieponice
Journal:  Front Biosci       Date:  2005-01-01

4.  Morphologic and mechanical characteristics of engineered bovine arteries.

Authors:  L E Niklason; W Abbott; J Gao; B Klagges; K K Hirschi; K Ulubayram; N Conroy; R Jones; A Vasanawala; S Sanzgiri; R Langer
Journal:  J Vasc Surg       Date:  2001-03       Impact factor: 4.268

5.  Tannin interactions with a full-length human salivary proline-rich protein display a stronger affinity than with single proline-rich repeats.

Authors:  A J Charlton; N J Baxter; T H Lilley; E Haslam; C J McDonald; M P Williamson
Journal:  FEBS Lett       Date:  1996-03-18       Impact factor: 4.124

6.  Tissue-engineered human vascular media produced in vitro by the self-assembly approach present functional properties similar to those of their native blood vessels.

Authors:  Karina Laflamme; Charles J Roberge; Stéphanie Pouliot; Pédro D'Orléans-Juste; François A Auger; Lucie Germain
Journal:  Tissue Eng       Date:  2006-08

7.  Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms.

Authors:  Jeanne M Connolly; Ivan Alferiev; Jocelyn N Clark-Gruel; Naomi Eidelman; Michael Sacks; Elizabeth Palmatory; Allyson Kronsteiner; Suzanne Defelice; Jie Xu; Rachit Ohri; Navneet Narula; Narendra Vyavahare; Robert J Levy
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

8.  Microvascular endothelial cell sodding of ePTFE vascular grafts: improved patency and stability of the cellular lining.

Authors:  S K Williams; D G Rose; B E Jarrell
Journal:  J Biomed Mater Res       Date:  1994-02

9.  Prevention of bioprosthetic heart valve tissue calcification by charge modification: effects of protamine binding by formaldehyde.

Authors:  G Golomb; V Ezra
Journal:  J Biomed Mater Res       Date:  1991-01

10.  In vitro endothelialization of bioprosthetic heart valves.

Authors:  T Fischlein; R Fasol
Journal:  J Heart Valve Dis       Date:  1996-01
View more
  19 in total

1.  Elastin-PLGA hybrid electrospun nanofiber scaffolds for salivary epithelial cell self-organization and polarization.

Authors:  Zahraa I Foraida; Tim Kamaldinov; Deirdre A Nelson; Melinda Larsen; James Castracane
Journal:  Acta Biomater       Date:  2017-08-08       Impact factor: 8.947

2.  Platform technologies for decellularization, tunic-specific cell seeding, and in vitro conditioning of extended length, small diameter vascular grafts.

Authors:  George Fercana; Devon Bowser; Margarita Portilla; Eugene M Langan; Christopher G Carsten; David L Cull; Leslie N Sierad; Dan T Simionescu
Journal:  Tissue Eng Part C Methods       Date:  2014-09-29       Impact factor: 3.056

3.  Lectin and antibody-based histochemical techniques for cardiovascular tissue engineering.

Authors:  Agneta Simionescu; Mary E Tedder; Ting-Hsien Chuang; Dan T Simionescu
Journal:  J Histotechnol       Date:  2011-03       Impact factor: 0.714

4.  Design and Testing of a Pulsatile Conditioning System for Dynamic Endothelialization of Polyphenol-Stabilized Tissue Engineered Heart Valves.

Authors:  Leslie Neil Sierad; Agneta Simionescu; Christopher Albers; Joseph Chen; Jordan Maivelett; Mary Elizabeth Tedder; Jun Liao; Dan T Simionescu
Journal:  Cardiovasc Eng Technol       Date:  2010-06       Impact factor: 2.495

5.  Stabilized Collagen and Elastin-Based Scaffolds for Mitral Valve Tissue Engineering.

Authors:  Christopher Deborde; Dan Teodor Simionescu; Cristopher Wright; Jun Liao; Leslie Neil Sierad; Agneta Simionescu
Journal:  Tissue Eng Part A       Date:  2016-10-03       Impact factor: 3.845

Review 6.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

7.  The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models.

Authors:  Timothy Pennel; George Fercana; Deon Bezuidenhout; Agneta Simionescu; Ting-Hsien Chuang; Peter Zilla; Dan Simionescu
Journal:  Biomaterials       Date:  2014-05-09       Impact factor: 12.479

8.  The acellular myocardial flap: a novel extracellular matrix scaffold enriched with patent microvascular networks and biocompatible cell niches.

Authors:  Jason B Schulte; Agneta Simionescu; Dan T Simionescu
Journal:  Tissue Eng Part C Methods       Date:  2013-01-16       Impact factor: 3.056

9.  Preclinical evaluation of collagen type I scaffolds, including gelatin-collagen microparticles and loaded with a hydroglycolic Calendula officinalis extract in a lagomorph model of full-thickness skin wound.

Authors:  D Millán; R A Jiménez; L E Nieto; I Linero; M Laverde; M R Fontanilla
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

10.  Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering.

Authors:  Dan T Simionescu; Joseph Chen; Michael Jaeggli; Bo Wang; Jun Liao
Journal:  J Healthc Eng       Date:  2012-06       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.